These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21335430)

  • 1. Thought exercises on accountability and performance measures at the National Heart, Lung, and Blood Institute (NHLBI): an invited commentary for circulation research.
    Lauer MS
    Circ Res; 2011 Feb; 108(4):405-9. PubMed ID: 21335430
    [No Abstract]   [Full Text] [Related]  

  • 2. Notes from the director of the National Heart, Lung, and Blood Institute: shaping the future of research: the NHLBI strategic plan.
    Nabel EG
    Circulation; 2007 Nov; 116(21):2479-80. PubMed ID: 18025405
    [No Abstract]   [Full Text] [Related]  

  • 3. NHLBI plans for the promise of cell-based therapies.
    Mondoro TH; Thomas JW; Henslee-Downey PJ; Peterson CM
    Cytotherapy; 2005; 7(4):317-27. PubMed ID: 16162453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ambitions and goals of the National Heart, Lung, and Blood Institute at The National Institute of Health.
    Eur Heart J; 2009 May; 30(10):1155-6. PubMed ID: 19443422
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity research and programs at the National Heart, Lung, and Blood Institute.
    Simons-Morton DG; Donato K; Loria CM; Pratt CA; Ershow AG; Morrissette MA; Czajkowski S; Arteaga SS; Obarzanek E
    J Am Coll Cardiol; 2010 Mar; 55(9):917-20. PubMed ID: 20185044
    [No Abstract]   [Full Text] [Related]  

  • 6. Notes from the NHLBI director: shaping the future of research--the NHLBI strategic plan.
    Nabel EG
    Am J Respir Crit Care Med; 2007 Dec; 176(12):1178. PubMed ID: 18057424
    [No Abstract]   [Full Text] [Related]  

  • 7. NHLBI announces SMARTT program.
    J Investig Med; 2011 Jun; 59(5):744. PubMed ID: 22121528
    [No Abstract]   [Full Text] [Related]  

  • 8. National heart, lung, and blood institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025.
    Lauer MS; Kiley JP; Mockrin SC; Mensah GA; Hoots WK; Patel Y; Cook NL; Patterson AP; Gibbons GH
    Circulation; 2015 Mar; 131(12):1106-9. PubMed ID: 25802256
    [No Abstract]   [Full Text] [Related]  

  • 9. Nanotechnology research support at the National Heart, Lung, and Blood Institute.
    Buxton DB
    Circ Res; 2011 Jul; 109(3):250-4. PubMed ID: 21778434
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in the research landscape require a new approach, while continuing to fund the highest scientific priorities. Jennifer Taylor talks with Dr Elizabeth Nabel, Director of the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) National Library.
    Nabel E
    Eur Heart J; 2009 Jun; 30(12):1423-5. PubMed ID: 19533911
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effectiveness research: welcome to the real world.
    Klein HG
    Transfusion; 2012 Jun; 52(6):1162-4. PubMed ID: 22686529
    [No Abstract]   [Full Text] [Related]  

  • 12. Notes from the Director, National Heart, Lung, and Blood Institute: NHLBI core values and shaping the 2007 budget.
    Nabel EG; Shurin SB
    Circulation; 2007 Aug; 116(6):683-4. PubMed ID: 17679630
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
    Douglas PS; Taylor A; Bild D; Bonow R; Greenland P; Lauer M; Peacock F; Udelson J
    J Cardiovasc Comput Tomogr; 2009; 3(4):212-23. PubMed ID: 19577208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac arrest and resuscitation: an opportunity to align research prioritization and public health need.
    Ornato JP; Becker LB; Weisfeldt ML; Wright BA
    Circulation; 2010 Nov; 122(18):1876-9. PubMed ID: 20956205
    [No Abstract]   [Full Text] [Related]  

  • 15. Current NHLBI perspectives on translational heart failure research.
    Lathrop DA; Skarlatos S
    J Mol Cell Cardiol; 2011 Oct; 51(4):441-3. PubMed ID: 20946899
    [No Abstract]   [Full Text] [Related]  

  • 16. NHLBI clinical trials workshop: an executive summary.
    Zheng G; Wu CO; Yang S; Waclawiw MA; DeMets DL; Geller NL
    Stat Med; 2012 Nov; 31(25):2938-43. PubMed ID: 22733431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the value of portfolio diversity in heart, lung, and blood research.
    Galis ZS; Hoots WK; Kiley JP; Lauer MS
    Circ Res; 2012 Sep; 111(7):833-6. PubMed ID: 22891047
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of the current regulatory environment on clinical research: An overview.
    Finlayson SR
    Surgery; 2009 Jun; 145(6):626-30. PubMed ID: 19486763
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons learned from the asthma clinical research network.
    Piazza B; Craig TJ
    J Am Osteopath Assoc; 2011 Nov; 111(11 Suppl 7):S18-26. PubMed ID: 22162374
    [No Abstract]   [Full Text] [Related]  

  • 20. Data safety monitoring boards: a word from a sponsor (NHLBI).
    Mondoro TH
    Transfusion; 2009 Aug; 49(8):1537-9. PubMed ID: 19413736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.